SCHEMBL9628085

SCHEMBL9628085

COC1=C(C(C)C)C(=O)c2cccc(-c3ccccc3)c2C1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.49
ALDH1A1 P00352 5/20 0.49
MITF O75030 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
HTT P42858 1/20 0.49
CDC25A P30304 6/20 0.47
CDC25B P30305 6/20 0.47
SMN1; SMN2 Q16637 4/20 0.46
RAB9A P51151 4/20 0.46
POLB P06746 3/20 0.46
KDM4E B2RXH2 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
LMNA P02545 2/20 0.46
HPGD P15428 2/20 0.46
MAP2K7 O14733 1/20 0.46
GMNN O75496 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9628046 0.82 MAPT (0.68) MAPTALDH1A1MITFNPSR1HTT
SCHEMBL9627830 0.80 CDC25A (0.49) MAPTALDH1A1MITFNPSR1HTT
SCHEMBL9641832 0.75 MAPT (0.48) MAPTALDH1A1MITFNPSR1HTT
SCHEMBL1038974 0.74 ADORA2A (0.57) MAPTALDH1A1CDC25BSMN1; SMN2RAB9A
SCHEMBL11424452 0.74 HDAC4 (0.52) MAPTALDH1A1HTTCDC25BSMN1; SMN2
Ammonia Solution, Strong SCHEMBL27523091 0.73 ADORA2A (0.55) MAPTALDH1A1CDC25BSMN1; SMN2RAB9A
SCHEMBL12626745 0.72 MAPT (0.52) MAPTALDH1A1HTTCDC25BSMN1; SMN2
SCHEMBL27971257 0.72 HDAC4 (0.50) MAPTALDH1A1HTTCDC25BSMN1; SMN2
SCHEMBL11121469 0.71 HDAC4 (0.58) MAPTALDH1A1MITFNPSR1HTT
SCHEMBL16491897 0.70 MEN1 (0.55) MAPTALDH1A1NPSR1HTTCDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155132-A Nonsteroidal antiinflammatory agents; treating psoriasis SYNTEX (U.S.A.) INC. (US) 1992-10-13 US disclosed
US-5134161-A Enzyme inhibitors for skin disorders, antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-07-28 US disclosed
US-5089657-A Topical antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-02-18 US disclosed
US-4786652-A TOPICAL ADMINISTRATION SYNTEX (U.S.A.) INC. (US) 1988-11-22 US disclosed
EP-0282056-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed
EP-0282006-A1 Naphtalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed
US-4758587-A Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-07-19 US disclosed